Daily topical application of imiquimod (TLR7 agonist) on the skin and ears of mice leads to a psoriasis-like dermatitis with many hallmarks of human psoriasis including skin thickening, hyperkeratosis, acanthosis, scaling and erythema16. This evidence concerns the gene TLR7 and psoriasis.